SCI时时刷

search
HIV T-cell immunogen design and delivery
HIV T-cell immunogen design and delivery
Purpose of the review Not all T-cell responses against HIV are created equally and responses of c
New vector and vaccine platforms: mRNA, DNA, viral vectors
New vector and vaccine platforms: mRNA, DNA, viral vectors
Purpose of review The purpose of this review is to share the excitement of new developments in th
Challenges of HIV therapeutic vaccines clinical trials design
Challenges of HIV therapeutic vaccines clinical trials design
Purpose of the review To discuss main challenges of therapeutic vaccine clinical trials design, i
Causes and outcomes of hepatic fibrosis in persons living with HIV
Causes and outcomes of hepatic fibrosis in persons living with HIV
Purpose of review The epidemiology of liver disease in people living with HIV has evolved since t
Editorial: HIV and cardiovascular disease: recognizing and reducing disparities
Editorial: HIV and cardiovascular disease: recognizing and reducing disparities
aDivision of General Internal Medicine bDivision of Infectious Diseases cMongan Institute, Massachusett...
Prevention of heart failure, tachyarrhythmias and sudden cardiac death in HIV
Prevention of heart failure, tachyarrhythmias and sudden cardiac death in HIV
Purpose of review To summarize the state-of-the-art literature on the epidemiology, disease progr
Cardiovascular disease risk in women living with HIV
Cardiovascular disease risk in women living with HIV
Purpose of review To synthesize current evidence on the impact of cardiovascular disease among wo
HIV and cardiovascular disease: the role of inflammation
HIV and cardiovascular disease: the role of inflammation
Purpose of review HIV and antiretroviral therapy (ART) use are linked to an increased incidence o
Towards a molecular profile of antiretroviral therapy-free HIV remission
Towards a molecular profile of antiretroviral therapy-free HIV remission
Purpose of review To summarize the current status and highlight recent findings on predictive bio
Elite and posttreatment controllers, two facets of HIV control
Elite and posttreatment controllers, two facets of HIV control
Purpose of review The quest for HIV-1 cure could take advantage of the study of rare individuals
Scaling up preexposure prophylaxis to maximize HIV prevention impact
Scaling up preexposure prophylaxis to maximize HIV prevention impact
Purpose of review Ten years since the first regulatory approval of oral HIV preexposure prophylax
The predictive value of macaque models of preexposure prophylaxis for HIV prevention
The predictive value of macaque models of preexposure prophylaxis for HIV prevention
Purpose of review We review macaque models for preexposure prophylaxis (PrEP) for HIV prevention
Promises and challenges: cabotegravir for preexposure prophylaxis
Promises and challenges: cabotegravir for preexposure prophylaxis
Purpose of review Tenofovir-based oral PrEP has been effective in reducing population-level HIV i
The future of long-acting agents for preexposure prophylaxis
The future of long-acting agents for preexposure prophylaxis
Purpose of review The main reason for the failure of oral preexposure prophylaxis (PrEP) regimens
HIV drug resistance in various body compartments
HIV drug resistance in various body compartments
Purpose of review HIV drug resistance testing using blood plasma or dried blood spots forms part
Technologies for HIV-1 drug resistance testing: inventory and needs
Technologies for HIV-1 drug resistance testing: inventory and needs
Purpose of review HIV-1 drug resistance (HIV DR) testing is routinely performed by genotyping pla
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?
Purpose of review To review current laboratory and clinical data on the frequency and relative ri
Role of islatravir in HIV treatment and prevention: an update
Role of islatravir in HIV treatment and prevention: an update
Purpose of review To summarize recent updates on the potential role of islatravir for HIV treatme
Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection
Purpose of review Anti-HIV-1 broadly neutralizing antibodies (bNAbs) are promising agents in the
Editorial: Is it time to implement injectable antiretroviral treatments globally?
Editorial: Is it time to implement injectable antiretroviral treatments globally?
aDepartment of HIV/GUM, Chelsea and Westminster Hospital bDepartment of Infectious Diseases, Imperial College...